当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2015年
1期
92-93
,共2页
小剂量低分子肝素%慢性肺心病%无创通气
小劑量低分子肝素%慢性肺心病%無創通氣
소제량저분자간소%만성폐심병%무창통기
Small doses of low molecular weight heparin%Chronic pulmonary heart disease%Non-invasive ventilation
目的:探讨小剂量低分子肝素联合无创通气对慢性肺心病急性加重期患者的治疗效果。方法选取38例慢性肺心病急性加重期患者作为研究对象,随机均分为实验组和对照组(n=19),2组患者均给予同样的内科基础治疗,实验组在此基础上,应用小剂量低分子肝素和无创通气。比较2组患者的血流变学、动脉血气、D-二聚体水平变化。结果实验组的治疗有效率为89.5%(17/19),对照组的治疗有效率为57.9%(11/19),实验组显著高于对照组(P<0.05);实验组治疗后的PaO 2水平显著高于对照组,PaCO 2水平显著低于对照组,差异均有统计学意义(P<0.05)。实验组治疗后的D-二聚体、红细胞比容、全血还原粘度、全血粘度均显著低于对照组,差异有统计学意义(P<0.05)。结论对于慢性肺心病急性加重期患者,采用小剂量低分子肝素联合无创通气进行治疗,能有效改善患者的缺氧症状,改善血液的高凝状态,治疗效果确切,值得推广应用。
目的:探討小劑量低分子肝素聯閤無創通氣對慢性肺心病急性加重期患者的治療效果。方法選取38例慢性肺心病急性加重期患者作為研究對象,隨機均分為實驗組和對照組(n=19),2組患者均給予同樣的內科基礎治療,實驗組在此基礎上,應用小劑量低分子肝素和無創通氣。比較2組患者的血流變學、動脈血氣、D-二聚體水平變化。結果實驗組的治療有效率為89.5%(17/19),對照組的治療有效率為57.9%(11/19),實驗組顯著高于對照組(P<0.05);實驗組治療後的PaO 2水平顯著高于對照組,PaCO 2水平顯著低于對照組,差異均有統計學意義(P<0.05)。實驗組治療後的D-二聚體、紅細胞比容、全血還原粘度、全血粘度均顯著低于對照組,差異有統計學意義(P<0.05)。結論對于慢性肺心病急性加重期患者,採用小劑量低分子肝素聯閤無創通氣進行治療,能有效改善患者的缺氧癥狀,改善血液的高凝狀態,治療效果確切,值得推廣應用。
목적:탐토소제량저분자간소연합무창통기대만성폐심병급성가중기환자적치료효과。방법선취38례만성폐심병급성가중기환자작위연구대상,수궤균분위실험조화대조조(n=19),2조환자균급여동양적내과기출치료,실험조재차기출상,응용소제량저분자간소화무창통기。비교2조환자적혈류변학、동맥혈기、D-이취체수평변화。결과실험조적치료유효솔위89.5%(17/19),대조조적치료유효솔위57.9%(11/19),실험조현저고우대조조(P<0.05);실험조치료후적PaO 2수평현저고우대조조,PaCO 2수평현저저우대조조,차이균유통계학의의(P<0.05)。실험조치료후적D-이취체、홍세포비용、전혈환원점도、전혈점도균현저저우대조조,차이유통계학의의(P<0.05)。결론대우만성폐심병급성가중기환자,채용소제량저분자간소연합무창통기진행치료,능유효개선환자적결양증상,개선혈액적고응상태,치료효과학절,치득추엄응용。
Objective To investigate the curative effects of small doses of low molecular weight heparin and non-invasive ventilation on patients with chronic pulmonary heart disease.Methods 38 patients with chronic pulmonary heart disease were selected as the study objects, and were randomly divided into experimental group and control group. Both of the two groups were given the same basic medical treatment, while the experimental group was given small doses of low molecular weight heparin and non-invasive ventilation on that basis. The blood rheology, arterial blood gas, D-dimer levels of these two groups were compared.Results The total effective rate of the experimental group was 89.5%(17/19), and the control group was 57.9%(11/19), showing that the effective rate of the experimental group was signiifcantly higher than that of the control group (P<0.05); After the treatment, PaO2 level of the experimental group was signiifcantly higher than control group, and PaCO2 level of the experimental group was signiifcantly lower than control group(P<0.05); After the treatment, D-dimer level, hematocrit value, WBRV and blood viscosity of the experimental group was signiifcantly higher than control group(P<0.05).Conclusion For patients with chronic pulmonary heart disease, the treatment of small doses of low molecular weight heparin and non-invasive ventilation can effectively improve the symptoms of hypoxia, blood hypercoagulable state, and effectiveness of treatment is exact, which is worthy of promotion.